Abnormal bone formation in CAPS patients is unaffected by IL-1 blockage (191), revealing that other pathways downstream NLRP3 inflammasome play important roles in the clinical manifestations. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.